Terumo Corp. (OTCMKTS:TRUMY) Short Interest Up 96.3% in August

Terumo Corp. (OTCMKTS:TRUMY) was the target of a significant growth in short interest in August. As of August 14th, there was short interest totaling 90,572 shares, a growth of 96.3% from the July 30th total of 46,134 shares. Based on an average trading volume of 104,726 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.0% of the company’s stock are short sold.

Analyst Ratings Changes

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Terumo currently has a consensus rating of “Buy”.

Terumo Trading Down 0.9%

Shares of OTCMKTS TRUMY opened at $15.69 on Tuesday. The firm’s 50 day moving average price is $14.65 and its 200-day moving average price is $13.88. The company has a market cap of $23.14 billion, a PE ratio of 22.10 and a beta of 0.68. Terumo has a 52-week low of $12.08 and a 52-week high of $18.83. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings results on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.55%. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.84 billion. On average, equities research analysts expect that Terumo will post 0.7 EPS for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.